This is often the case in outpatient consultations:
After a series of difficult treatments, the situation has finally stabilized, and many of the patients may feel relieved and feel comfortable.
However, Dr. Huang was always patient in reminding patients to return for regular review.
This puzzles a lot of patients: “Why do you have to review so often when the condition is stable?”
Why regular review?
The systematic erythalamus (SLE) is a multisystem, ceremonial, ceremonial, undetected chronic self-immunological disease with a “recurring and repeated” characteristic.
Research data show that SLE patients have a total risk of relapse of up to 60 per cent in 4 years of stable condition.
Even when treated, the disease reaches a period of stability, it cannot be taken lightly, as any minor change can be a precursor to its recurrence. Regular reviews help doctors to detect changes in the situation in a timely manner and take effective measures to intervene to prevent further deterioration of the disease.
In addition, the long-term use of certain drugs, such as hormones and immunosuppressants, can lead to adverse effects such as osteoporosis, infections and hypertension, and periodic examinations can monitor the physical effects of these drugs and ensure the safety of treatment.
Indeed, both SLE and other rheumatological diseases should be reviewed regularly.
How often do you need to review it?
The frequency of periodic review is not constant, but needs to be determined in the specific case of the patient. In accordance with the recommendations of the Guide to the systematic treatment of red weeds in China (version 2020):
Period of activity: at least one month should be reviewed to closely monitor changes in the condition and the efficacy of the medication.
Stable period: Review every 3-6 months to assess the long-term control of the condition and the side effects of the drug.
Re-emergence: dealt with on an active basis, at least once every one month, until the condition is stable.
At the same time, SLE patients also need to pay close attention to the physical changes, and should the following symptoms occur, they may be re-emerging, and even before the time of review, they should be treated immediately.
1 Unidentified fever;
2 Rapid spread of new or old rashes;
There has been a marked increase in the number of disempowerments;
4 New mouth, nose ulcer;
The presence of cortex or cardiac enzymes;
6 Symptoms of the nervous system, such as headaches.
What are the items for review?
The SLE review projects usually include a series of routine examinations, such as blood, urine, liver and kidney function, coagulation function, red cell deposition rates, etc., which help doctors to make preliminary judgements about the basic state of the body.
In addition, blood sugar, blood resin, vaccinations (immunoglobins, patches C3 and C4), 24-hour urine proteomics, anti-nucleic spectrums, anti-phosphate antibodies, etc. are assessed according to the individual condition.
The combination of these screening projects provides a comprehensive picture of SLE patients ‘ immune status and organ function and provides a basis for the development of individualized treatment programmes by doctors.
The details of life are equally important.
In addition to regular review and medication, patients also need to pay attention to the details of everyday life.
Maintaining healthy living habits, such as a reasonable diet, adequate exercise, adequate sleep and the avoidance of overwork, all contribute to increasing physical immunity and reducing the risk of a relapse into disease.
Optimistic mentalities are also important, and emotional volatility may affect the proper functioning of the immune system, thereby increasing the likelihood of a relapse into disease.
Carnation: This is based on the sharing of diseases and is not a substitute for hospital visits. Comments are for reference purposes only, and medical advice is required for specific treatments.
References:
[1] Zhou Myungju, Kan Shyran, Natsumi. Systemic management of slow disease of red hyenas [J]. Chinese Journal of dermatological pathology, 2023, 37 (11): 1222-1226.[2] Thank you very much. Lee Zhijun. Systemical diagnosis and treatment of red hyenas [J]. J]. China General Medicine 2020, 18 (04): 527-528.[3]2020 Guide to systematic erythalamus treatment in China
